Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy

References

Page 1

	Year	Citations
Regression Models and Life-Tables D. R. Cox Journal of the Royal Statistical Society Series B (Statistical Methodology) Regression ModelsReliability EngineeringConditional LikelihoodEngineeringLife Prediction	1972	38.8K
Nonparametric Estimation from Incomplete Observations Edward L. Kaplan, Paul Meier Journal of the American Statistical Association EngineeringAgingLife PredictionRare Event EstimationMortality Rates	1958	38.7K
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer David Cunningham, Yves Humblet, Salvatore Siena, New England Journal of Medicine	2004	5K
An endotoxin-induced serum factor that causes necrosis of tumors. E A Carswell, Lloyd J. Old, Robert Kassel, Proceedings of the National Academy of Sciences InflammationResidual EndotoxinTumor Necrosis FactorEndotoxin-induced Tumor NecrosisCytokine	1975	4.5K
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer Christos S. Karapetis, Shirin Khambata‐Ford, Derek J. Jonker, New England Journal of Medicine	2008	3.6K
Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer Rafael G. Amado, Michael Wolf, Marc Peeters, Journal of Clinical Oncology	2008	3.1K
A note on quantifying follow-up in studies of failure time M. Schemper, Terry L. Smith Controlled Clinical Trials ReliabilitySoftware MaintenanceReliability EngineeringEngineeringManagement	1996	2.5K
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200 Bruce J. Giantonio, Paul J. Catalano, Neal J. Meropol, Journal of Clinical Oncology	2007	2.3K
Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Eric Van Cutsem, Marc Peeters, Salvatore Siena, Journal of Clinical Oncology	2007	2K
Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer Steven J. Cohen, Cornelis J.A. Punt, Nicholas Iannotti, Journal of Clinical Oncology	2008	1.8K

Page 1